U.S. pharma big copyright scrapped two experimental weight loss pills final 12 months—a at the time-daily pill, lotiglipron, because of elevated liver enzymes and also a two times-everyday capsule, danuglipron, because of potent Unwanted effects—but CEO Albert Bourla has reported the company is decided to “Engage in and earn” within the obe